Themes

India’s CDSCO approves Bharat Biotech’s intra-nasal vaccine for Covid-19

The BBV154 vaccine is approved for the first two-dose schedule and homologous booster doses.

Artificial Intelligence

View More

Cloud

View More

Corporate Governance

View More

Cybersecurity

View More

Environmental Sustainability

View More

Internet of Things

View More

Robotics

View More

Social Responsibility

View More

Covid-19

View More